SCHEMBL10967305

SCHEMBL10967305

COc1ccc(-c2ncn(C)c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.58
KDM2B Q8NHM5 2/20 0.58
KDM4C Q9H3R0 2/20 0.58
KDM5B Q9UGL1 2/20 0.58
PTGS2 P35354 4/20 0.56
MAPK14 Q16539 1/20 0.55
NSD3 Q9BZ95 1/20 0.54
NSD2 O96028 2/20 0.48
PDE10A Q9Y233 1/20 0.47
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18579665 0.82 KDM4C (0.61) KDM5AKDM2BKDM4CKDM5BNSD3
SCHEMBL19125499 0.80 HDAC8 (0.75) KDM5AKDM2BKDM4CKDM5BPTGS2
SCHEMBL17434351 0.80 KDM2B (0.53) KDM5AKDM2BKDM4CKDM5BPTGS2
SCHEMBL17434349 0.80 HDAC8 (0.75) KDM5AKDM2BKDM4CKDM5BPTGS2
SCHEMBL18041832 0.80 TGFBR1 (0.57) KDM5AKDM2BKDM4CKDM5BCLK4
SCHEMBL18041773 0.79 TGFBR1 (0.68) KDM5AKDM2BKDM4CKDM5BNSD2
SCHEMBL4085395 0.78 MAPK14 (0.58) KDM5AKDM2BKDM4CKDM5BMAPK14
SCHEMBL1009513 0.77 NSD3 (0.83) KDM2BKDM4CPTGS2MAPK14NSD3
SCHEMBL17596821 0.77 KDM5A (0.44) KDM5AKDM2BKDM4CKDM5BNSD2
SCHEMBL10969997 0.77 PTGS2 (0.66) PTGS2MAPK14PDE10AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102190625-A Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2011-09-21 CN claimed
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 CN disclosed
CN-102190625-A Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2011-09-21 CN disclosed
EP-0043788-B1 IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS SCHERING AKTIENGESELLSCHAFT (DE) 1985-10-30 EP disclosed
US-4528298-A Antiinflammatory imidazole derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1985-07-09 US disclosed
US-4503065-A ANTIARTHRITIC, ANALGESIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-03-05 US disclosed
US-4402960-A Antiinflammatory imidazole derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1983-09-06 US disclosed
US-4372964-A ANAGESIC, ANTIARTHRITIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1983-02-08 US disclosed
EP-0043788-A1 Imidazole derivatives, process for their preparation and their pharmaceutical compositions SCHERING AKTIENGESELLSCHAFT (DE) 1982-01-13 EP disclosed
EP-0032113-A2 Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1H-imidazole-2-methanols E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-07-15 EP disclosed